Cell-to-cell variability in Myc dynamics drives transcriptional heterogeneity in cancer cells

Cell Rep. 2023 Apr 25;42(4):112401. doi: 10.1016/j.celrep.2023.112401. Epub 2023 Apr 14.

Abstract

Cell-to-cell heterogeneity is vital for tumor evolution and survival. How cancer cells achieve and exploit this heterogeneity remains an active area of research. Here, we identify c-Myc as a highly heterogeneously expressed transcription factor and an orchestrator of transcriptional and phenotypic diversity in cancer cells. By monitoring endogenous c-Myc protein in individual living cells, we report the surprising pulsatile nature of c-Myc expression and the extensive cell-to-cell variability in its dynamics. We further show that heterogeneity in c-Myc dynamics leads to variable target gene transcription and that timing of c-Myc expression predicts cell-cycle progression rates and drug sensitivities. Together, our data advocate for a model in which cancer cells increase the heterogeneity of functionally diverse transcription factors such as c-Myc to rapidly survey transcriptional landscapes and survive stress.

Keywords: CP: Cancer; CP: Cell biology; Myc; cancer; cell-to-cell heterogeneity; gene expression; transcription.

MeSH terms

  • Cell Line, Tumor
  • Gene Expression Regulation
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Neoplasms* / genetics
  • Proto-Oncogene Proteins c-myc* / genetics
  • Proto-Oncogene Proteins c-myc* / metabolism
  • Transcription Factors / metabolism

Substances

  • Proto-Oncogene Proteins c-myc
  • Transcription Factors